Bourlon, M. T., Bourlon, M. T., Galli, L., Grande, E., Park, S. H., Melichar, B., . . . Santoni, M. (2025). Nivolumab plus cabozantinib in metastatic renal cell carcinoma: Real-world evidence from the international ARON-1 study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationBourlon, Maria T., et al. Nivolumab Plus Cabozantinib in Metastatic Renal Cell Carcinoma: Real-world Evidence from the International ARON-1 Study. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationBourlon, Maria T., et al. Nivolumab Plus Cabozantinib in Metastatic Renal Cell Carcinoma: Real-world Evidence from the International ARON-1 Study. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.